The government's kneejerk reaction to allow patients to top-up NHS care with treatment paid for privately is another nail in the coffin of the universal healthcare. We believe sanctioning top-ups is too simple an answer to a very thorny, complex and emotional issue, and doing so risks some serious unintended consequences. There is a danger that this might appease middle England but disregard the real health challenges facing us.
The NHS drugs watchdog has loosened the terms of approval for expensive treatments that extend life in patients with a short life expectancy. Drugs that would normally be ruled out of use on the NHS because they did not represent a cost effective use of resources are now more likely to be made available.
The UK government has quietly dropped a passage in the draft handbook to the NHS constitution that said that ministers had decided to give researchers the right to trawl medical records for research participants without the need for patients’ consent. Organisations that are charged with safeguarding patient confidentiality had objected strongly to a section in the draft handbook that said, "Patients can . . . expect that a health professional or a research professional who owes the same duty of confidentiality as a health professional may use care records, in confidence, to identify whether they are suitable to participate in approved clinical trials. Appropriate patients will be notified of opportunities to join in, and will be free to choose whether they wish to do so, after a full explanation."
The confidentiality of medical records is threatened by government plans to relax laws on data protection, doctors' leaders told the Guardian yesterday. Dr Hamish Meldrum, chairman of the British Medical Association, said the profession was "extremely concerned" about legislation tabled by Jack Straw, the justice secretary, which would allow the Department of Health to share information on NHS databases with other ministries and private companies.